Skip to content

Coxsackievirus A2 Antibody Test (Complement Fixation)

Published: August 9, 2026Updated: August 10, 2026

This blood test measures antibodies against Coxsackievirus A2 in your blood using a laboratory method called complement fixation. It helps your healthcare provider find out whether your immune system has responded to a recent or past Coxsackievirus A2 infection, which can cause symptoms like fever, sore throat, rash, or heart-related complications such as myocarditis, and supports an accurate diagnosis of related infections.

Quick summary

{"Detects antibodies to Coxsackievirus A2, an enterovirus that can cause hand-foot-and-mouth disease and other infections","Uses complement fixation test to measure antibody levels (titers) in blood serum","Helps diagnose recent or past Coxsackievirus A2 infections, particularly when cardiac or neurological symptoms are present","Sample is collected through a simple blood draw","Results are reported as antibody titers, with higher levels indicating stronger immune response"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 10, 2026Editorial policy

Key facts at a glance

LOINC
9753-5
Short code
COXA2CF
Synonyms
CV A2 Ab Titr Ser CF
Category
cardiac
Sample
serum
Container
SST (Serum Separator Tube) or red top glass tube
Units
N/A
Ref low
8
Ref high
8
Fasting
false
Population
adult
Sex
all
Age range
0–120 years
Method
comp-fix
CPT
86658
SNOMED
122449000
Specimen volume
1.0 mL minimum, 2.0 mL preferred
Stability
Room temperature: 8 hours; Refrigerated (2-8°C): 48 hours; Frozen (-20°C or below): 7 days. Avoid repeated freeze-thaw cycles.
Hemolysis max
50
Lipemia max
40
Icterus max
20
TAT
72–168 hours
Order
routine

What is this test?

The Coxsackievirus A2 antibody test is a blood test that detects and measures specific antibodies (called IgG and IgM) against Coxsackievirus A2 in your blood serum. The test uses a laboratory method called complement fixation, which can determine whether your immune system has produced antibodies in response to a Coxsackievirus A2 infection. This test is often ordered when patients show symptoms that may be related to Coxsackievirus infection, especially when cardiac complications are suspected.

Why is it ordered?

Healthcare providers may order this test to: (1) Confirm a suspected Coxsackievirus A2 infection in patients with symptoms such as fever, sore throat, rash (particularly on hands, feet, and mouth), or vesicles in the mouth; (2) Investigate the cause of myocarditis (heart muscle inflammation) or pericarditis (heart lining inflammation) when Coxsackievirus is suspected as the underlying cause; (3) Determine if a patient has been previously exposed to Coxsackievirus A2; (4) Monitor antibody levels in certain clinical situations.

How is the test performed?

A healthcare professional will draw a small blood sample from a vein in your arm. The blood is collected in a tube and sent to a laboratory for analysis. In the laboratory, technicians use the complement fixation test method, which detects whether specific antibodies in your blood can bind to Coxsackievirus A2 antigens and trigger the complement system. The results are reported as a titer, which indicates the highest dilution of your blood serum that still shows a positive reaction.

What do the results mean?

Results are typically reported as a titer (for example, 1:8, 1:32, 1:64). A fourfold increase in antibody titer between two blood samples taken 2-4 weeks apart indicates a recent or ongoing infection. A single elevated titer may indicate past exposure to the virus. Your healthcare provider will interpret the results in the context of your symptoms, physical examination, and other test results to make an accurate diagnosis.

Reference range

Less than 1:8 (negative); 1:8 (borderline); Greater than 1:8 (positive). A four-fold rise in titer between acute and convalescent samples indicates recent or ongoing infection.N/A

Specimen: serum

No special preparation required. Fasting is not necessary for this test.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Coxsackievirus A2 is a member of the Enterovirus genus and is a common cause of hand-foot-and-mouth disease (HFMD) in children, characterized by fever, sore throat, and painful blisters on the hands, feet, and inside the mouth. While most infections are mild and self-limiting, Coxsackieviruses can occasionally cause more serious complications, including myocarditis (inflammation of the heart muscle), pericarditis (inflammation of the heart lining), aseptic meningitis, and encephalitis. This test helps clinicians identify whether a patient has been infected with Coxsackievirus A2, which is particularly important when cardiac symptoms are present, as it can guide treatment decisions and help determine prognosis.

The complement fixation test is a classic serological method that detects virus-specific antibodies by measuring their ability to fix (consume) complement proteins. A positive result indicates that the patient's immune system has produced specific antibodies against Coxsackievirus A2. The presence of IgM antibodies typically indicates a recent infection, while IgG antibodies suggest past exposure or immunity. This test is particularly useful in epidemiological studies and outbreak investigations to determine the prevalence of Coxsackievirus A2 infections in communities.

Frequently asked questions

Do I need to fast before this test?
No, fasting is not required for this blood test. You can eat and drink normally before the test. However, follow any specific instructions provided by your healthcare provider.
Is this test painful?
You may feel a brief sting or pinch when the needle is inserted to draw blood. This is typically well-tolerated, and the discomfort is minimal and temporary. After the blood draw, you may have slight bruising or soreness at the needle site, which usually resolves quickly.
How long does it take to get results?
The time to receive results varies by laboratory, but it typically takes 3-7 days. Your healthcare provider will contact you with the results or discuss them at your follow-up appointment.
What is the difference between IgM and IgG antibodies?
IgM antibodies are produced first during an infection and usually indicate a recent or active infection. IgG antibodies develop later and provide long-term immunity. The complement fixation test may detect both types, and your doctor will interpret the results based on which antibodies are present and their levels.
Do I need treatment if the test is positive?
Most Coxsackievirus A2 infections are mild and resolve on their own within 7-10 days. Treatment is usually supportive and may include rest, fluids, and medications to relieve symptoms such as fever or pain. However, if complications like myocarditis occur, more specific treatment may be needed. Always follow your healthcare provider's recommendations.
Can I get Coxsackievirus A2 more than once?
After recovering from a Coxsackievirus A2 infection, you typically develop immunity to that specific type. However, there are many different strains of Coxsackieviruses, so you could potentially be infected with a different type in the future. Good hygiene practices, such as regular handwashing, can help reduce the risk of infection.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 10, 2026. · Read our editorial policy